Skip to product information
1 of 1

Elabscience

SKU:E-AB-F1141H-50Tests

PE/Cyanine7 Anti-Human CD10 Antibody[HI10a]

PE/Cyanine7 Anti-Human CD10 Antibody[HI10a]

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
The PE/Cyanine7 Anti-Human CD10 Antibody [HI10A] is a highly reliable and efficient tool for the detection and analysis of CD10 expression in human samples. This antibody is conjugated with PE/Cyanine7, a fluorochrome that emits a strong signal in the red-orange spectrum, allowing for easy identification and quantification of CD10-positive cells.

CD10, also known as Neprilysin or Common Acute Lymphoblastic Leukemia Antigen (CALLA), is a cell surface enzyme that plays a crucial role in various physiological and pathological processes. It is expressed on a wide range of cell types, including lymphoid and myeloid cells, as well as certain non-hematopoietic cells.

The PE/Cyanine7 Anti-Human CD10 Antibody [HI10A] exhibits exceptional specificity and sensitivity, ensuring accurate and reproducible results. It has been extensively validated for flow cytometry applications, enabling the identification and characterization of CD10-positive cells in complex biological samples.

This antibody is supplied in a liquid format, ready for immediate use. It is provided in a convenient vial size, ensuring minimal waste and maximum cost-effectiveness. The PE/Cyanine7 conjugate offers excellent photostability, allowing for prolonged sample analysis without compromising signal intensity.

The PE/Cyanine7 Anti-Human CD10 Antibody [HI10A] is an indispensable tool for researchers and clinicians involved in the study of hematopoiesis, immunology, and oncology. Its high performance and ease of use make it an ideal choice for a wide range of applications, including immunophenotyping, cell sorting, and monitoring disease progression.

Order your PE/Cyanine7 Anti-Human CD10 Antibody [HI10A] today and unlock the potential of CD10 analysis in your research or diagnostic endeavors.
View full details